Nrx Pharmaceuticals, INC. (NRXPW) SEC Filings — 2024
33 SEC filings for Nrx Pharmaceuticals, INC. (NRXPW) in 2024.
Filings
- NRX Pharmaceuticals Appoints Dr. Javitt CEO, Chairman — 8-K · Nov 20, 2024
- NRX Pharmaceuticals Files 8-K on Financials — 8-K · Nov 15, 2024
- NRX Pharmaceuticals Files S-1 Registration Statement — S-1 · Nov 14, 2024
- NRX Pharmaceuticals Files 8-K — 8-K · Oct 31, 2024
- NRX Pharma Files 8-K on Financial Obligations & Equity Sales — 8-K · Oct 15, 2024
- NRX Pharmaceuticals Files 8-K on Corporate Governance Changes — 8-K · Oct 11, 2024
- NRX Pharmaceuticals Files 2024 Proxy Statement — DEF 14A · Sep 5, 2024
- NRX Pharmaceuticals Board Changes and Officer Compensation — 8-K · Aug 20, 2024
- NRX Pharmaceuticals Files 8-K on Financials — 8-K · Aug 15, 2024
- NRX Pharmaceuticals Files 10-Q, Details Stock Changes — 10-Q · Aug 14, 2024
- NRX Pharmaceuticals Faces Delisting Concerns — 8-K · Aug 12, 2024
- NRX Pharmaceuticals Terminates Material Agreement — 8-K · Jun 27, 2024
- NRX Pharmaceuticals Reports Director/Officer Changes & Financials — 8-K · Jun 20, 2024
- NRX Pharmaceuticals Closes $10M Convertible Note Offering — 8-K · May 23, 2024
- NRX Pharmaceuticals Files 8-K — 8-K · May 16, 2024
- NRX Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- NRX Pharmaceuticals Files 8-K on Financial Obligations — 8-K · Apr 30, 2024
- NRX Pharmaceuticals Files Amendment to 2023 Annual Report — 10-K/A · Apr 29, 2024
- NRX Pharmaceuticals Enters Material Definitive Agreement — 8-K · Apr 19, 2024
- NRX Pharmaceuticals Files 8-K — 8-K · Apr 15, 2024
- NRX Pharmaceuticals Files 8-K on Financials — 8-K · Apr 2, 2024
- NRX Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
- NRX Pharmaceuticals Files 8-K on Security Holder Rights — 8-K · Mar 28, 2024
- NRX Pharmaceuticals Files 8-K — 8-K · Mar 21, 2024
- NRX Pharmaceuticals Files Proxy Statement — DEFA14A · Mar 20, 2024
- NRX Pharma Files Proxy Statement for Share Distribution — DEFA14A · Mar 18, 2024
- NRX Pharmaceuticals Files Proxy Statement — DEFA14A · Mar 13, 2024
- NRX Pharmaceuticals to Hold Special Meeting of Stockholders on March 21, 2024 — DEF 14A · Mar 11, 2024
- NRX Pharmaceuticals Files 8-K — 8-K · Mar 6, 2024
- NRX Pharma Sells Equity, Warrants in Unregistered Offering — 8-K · Feb 28, 2024
- NRX Pharma Reports Undisclosed Material Agreement — 8-K · Feb 14, 2024
- NRXP Faces Nasdaq Delisting for Bid Price Non-Compliance — 8-K · Feb 2, 2024
- NRX Pharmaceuticals Faces Delisting Threat, Files 8-K — 8-K · Jan 23, 2024